ABSTRACT. Trichoepithelioma is a benign neoplasm that primarily shows follicular germinative differentiation. Classic trichoepithelioma typically presents as a skin-colored papule or nodule on the face or upper trunk; lesions have a predilection for the nose. Trichoepithelioma can be sporadic or familial and solitary or multiple. Most previously reported multiple trichoepithelioma cases are familial, and germline CYLD mutations could be detected in some patients. We performed mutational analysis of the germline CYLD gene in 8 Chinese multiple trichoepitheliomas patients, 6 of which were sporadic cases. A heterozygous missense mutation (c.1112C>A) in the 9th exon of the CYLD gene was detected in some mother-daughter patients. However, the germline CYLD mutation could not be detected in the 6 non-
INTRODUCTION
Trichoepithelioma is a benign tumor originating from hair follicles. The multiple lesions are characterized by skin-colored papules and nodules located around the nose, nasolabial folds, upper lip, forehead, and occasionally on the scalp, neck, and upper trunk. Although malignant changes are rare in these lesions, cosmetic issues can affect a patient's mental health. Histopathogically, the tumor consists of nodules of basaloid cells in a fibrous stroma with papillae, small horny cysts, and conspicuous follicular germs. Trichoepithelioma occurs as either solitary or multiple and non-familial or familial cases. In general, multiple lesions are associated with genetic predisposition, whereas solitary lesions involve sporadic cases. In 2004, Zhang et al. (2004) identified the pathogenic gene responsible for multiple familial trichoepitheliomas (MFT) on chromosome 16q12-13 and identified CYLD as the target gene. The relationship between MFT and the CYLD gene was further confirmed in many other pedigrees (Zuo et al., 2007; Chen et al., 2011; Ying et al., 2012) . We recruited 8 multiple trichoepitheliomas patients for the present study, including 6 sporadic cases and 2 mother-daughter relationships. We then conducted genetic analysis of the CYLD gene in the 8 patients to determine whether these cases were related to abnormalities in the CYLD gene.
MATERIAL AND METHODS

Subjects
The study included 8 Chinese patients with multiple trichoepitheliomas, 6 females aged 8-40 years, and 2 males with ages of 9 and 46 years, respectively. All 8 patients showed numerous skin-colored, dome-shaped, firm nodules and papules on the face and nose, with a size range of 2-8 mm ( Figure 1 and Table 1 ). All patients were examined by experienced dermatologists and were diagnosed with trichoepitheliomas based on clinical features; 3 patients (patients 1, 6, and 7) were also confirmed by pathological examination.
Mutational analysis
After obtaining written informed consent from patients, blood was collected from the patients. Genomic DNA was extracted using Wizard ® Genomic DNA Purification Kit (Promega; Madison, WI, USA) according to the manufacturer protocol. In addition, genomic DNA from 100 normal healthy Chinese individuals was used as control. All exons of the CYLD gene with intronic flanking sequences were amplified by polymerase chain reaction (PCR). Primer sequences for the 9th exon were designed as follows: forward, 5'-TCCTGTTTCCCTCCTATCT TGACT-3' and reverse, 5'-CAGCAGTACGGTTCAAACTGTGTA-3'. PCR products were purified using the QIAquick PCR Purification Kit (Qiagen; Hilden, Germany) and sequenced using an ABI Prism 3730 automated sequencer (Applied Biosystems; Foster City, CA, USA). Sequence comparisons and analyses were performed using Phred-Phrap-Consed version 12.0 (http://www.phrap.org). 
RESULTS
Sequencing analysis of the coding regions flanking the exons of the CYLD gene in the 6 sporadic multiple trichoepitheliomas cases and 100 controls showed no germline mutations, whereas in the mother-daughter patients, we detected a heterozygous missense mutation (c.1112C>A) in the 9th exon of the CYLD gene (Figure 2 ). 
DISCUSSION
In 1996, Harada et al. (1996) located a pathogenic gene of MFT on 9p21, but its target gene has not been identified, and there are many tumor suppressor genes in this location. In 2004, Zhang et al. (2004) found that the CYLD gene located on chromosome 16q12-13 was the pathogenic gene for MFT in a Chinese pedigree. The expression product of CYLD belongs to the deubiquitinating enzyme family and plays a pivotal role in the negative regulation of nuclear factor-kB and c-Jun N-terminal kinase signal. CYLD was initially identified as the target gene of Brooke-Spiegler syndrome (BSS) and cylindroma. The adnexal tumors involved in BSS include trichoepitheliomas. This suggests that uncomplicated trichoepitheliomas without other adnexal tumors represent a pole within the spectrum of BSS.
Previously reported trichoepitheliomas cases with germline mutations in CYLD were familial; however, the germline mutation could not be detected in all familial cases. Ponti et al. (2012) reported an MFT patient without abnormalities in CYLD. Saggar et al. (2008) , Kazakov et al. (2011) , and Grossmann et al. (2013) reported 9, 13, and 18 MFT patients, respectively, in which a germline mutation in CYLD was found in only 4 (44.4%), 6 (46%), and 8 (44.4%) cases, respectively. There have been few studies examining multiple trichoepitheliomas without a family history. Six of the 8 patients who participated in our study had multiple lesions, whereas germline mutations were not detected. We speculated that the onset of these patients may be related to the following factors. Some mutations may lie in non-coding regions, as was observed in a case of BSS reported by Kazakov et al. (2010) in which a deep intronic mutation was identified. Gross rearrangements and chromosomal deletions are also potential factors. van den Ouweland et al. (2011) identified a gross chromosomal rearrangement spanning approximately 5 kb involving the CYLD gene in a patient with familial cylindromatosis. Somatic mutation may also be important. Vorechovský et al. (1997) reported 2 cases with frameshift mutations and in-frame somatic deletions in the CYLD gene. Somatic mutations were detected in 2 and 3 of the 7 and 10 cases lacking germline CYLD mutations, respectively, as reported by Kazakov et al. (2011) and Grossmann (2013) . However, equally important is that trichoepitheliomas displays genetic heterogeneity and may thus contain gene abnormalities other than those in CYLD, such as some CYLD-regulating genes that may map to the undetermined 9q21 or 9p22 regions. Other results indicate that sporadic trichoepitheliomas are not related to BSS and that the pathogenesis must be further examined .
The c.1112C>A mutation identified in the mother-daughter patients has been reported in many other studies, indicating that this mutation is a potential hotspot. However, this mutation has not been reported in Chinese patients. Further studies are required to determine whether the c.1112C>A mutation is also a hotspot in Chinese multiple familial trichoepitheliomas patients. The c.1112C>A mutation may be related to both cylindromatosis and trichoepitheliomas, and the mechanism remains unclear regarding how the same mutation can cause different phenotypes in BSS.
In conclusion, we reported 8 cases of trichoepitheliomas, 6 of which lack a family history. Because germline CYLD mutations were not detected in the 6 sporadic cases, further studies must be conducted to confirm the genetic heterogeneity of the disease. The somatic mutation should be detected in tumor tissues and other possible pathogenic genes should be further explored.
